TY  - GEN
AU  - Blumenfeld,Shiri
AU  - Staun-Ram,Elsebeth
AU  - Miller,Ariel
TI  - Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis
SN  - 1095-9157
PY  - 2017///0406
KW  - Adult
KW  - Antigen Presentation
KW  - immunology
KW  - B-Lymphocyte Subsets
KW  - cytology
KW  - Cell Differentiation
KW  - drug effects
KW  - Cell Survival
KW  - Cytokines
KW  - metabolism
KW  - Female
KW  - Fingolimod Hydrochloride
KW  - pharmacology
KW  - Gene Expression
KW  - Humans
KW  - Immunologic Memory
KW  - Immunophenotyping
KW  - Immunosuppressive Agents
KW  - Inflammation Mediators
KW  - Interleukin-10
KW  - biosynthesis
KW  - Leukocyte Count
KW  - Lymphocyte Activation
KW  - Lymphocyte Count
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis
KW  - diagnosis
KW  - Plasma Cells
KW  - Receptors, Lysosphingolipid
KW  - genetics
KW  - Sphingosine-1-Phosphate Receptors
KW  - Transforming Growth Factor beta
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jaut.2016.03.012
ER  -